Physicians' Dilemma of False-Positive RT-PCR for COVID-19: a Case Report

Sayak Roy1

  • 1Department of Internal Medicine, Medica Superspeciality Hospital, Kolkata, India.

Insights

Reverse transcription-polymerase chain reaction (RT-PCR) is the standard for diagnosing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Emerging false-positive results complicate medical decisions and health data accuracy.

Area of Science:

  • Medical Diagnostics
  • Virology
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) has caused significant global health and economic disruption since December 2019.
  • Reverse transcription-polymerase chain reaction (RT-PCR) is the established gold standard for detecting SARS-CoV-2, the virus responsible for COVID-19.

Purpose of the Study:

  • To highlight the diagnostic challenges posed by false-positive results in SARS-CoV-2 detection.
  • To discuss the implications of inaccurate diagnostic data on clinical practice and public health management.

Main Methods:

  • Review of current diagnostic protocols for SARS-CoV-2.
  • Analysis of reported instances and impact of false-positive RT-PCR results.

Main Results:

  • RT-PCR, while standard, is susceptible to occasional false-positive outcomes.
  • These inaccuracies present diagnostic dilemmas for physicians.
  • False positives can compromise the integrity of health statistics and epidemiological tracking.

Conclusions:

  • The issue of false-positive RT-PCR tests for SARS-CoV-2 requires attention.
  • Addressing these inaccuracies is crucial for reliable patient management and accurate public health surveillance.